Poland· PL-100369481
Vessel Due F
A sulodexid product containing sulodexidum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sulodexid is registered in 2 of 19 countries.
Countries holding a registration under ATC B01AB11 (sulodexid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Sulodexid · ATC B01AB11
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Sulodexidum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B01AB11
- ATC class
- Sulodexid
- Defined daily dose
- 500 LSU, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991272944
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulodexid in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVESSEL DUE FAlfasigma S.p.A., Bologna
- SpainATERINA 15 mg CAPSULAS BLANDASAlfasigma Espana S.L.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Bulgaria · Трепарин
- Czechia · Vessel Due F
- Spain · Aterina, Dovida
- Hungary · Vessel Due, Vessel Due F
- Italy · Angioflux, Provenal
- Portugal · Treparin, Vessel
- Romania · Coreflux, Vessel Due F
- Slovakia · Vessel Due F
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b53f1f20-547b-4df7-bb85-3b6f00117d9f GET /v1/drugs/b53f1f20-547b-4df7-bb85-3b6f00117d9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "300 LSU/ml",
"packaging": "05909991272944 ¦ Rp ¦ 115364\n10 amp. 2 ml",
"substance": "Sulodexidum 300 LSU/ml",
"common_name": "Sulodexidum",
"pl_product_id": "100369481",
"pozwolenie_nr": "230/16",
"auth_procedure": "IR",
"authorisation_validity": "2031-04-19"
}See everything about sulodexid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.